Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Cochrane Database of Systematic Reviews
|
August 22, 2025
FcRn inhibitors for myasthenia gravis
Laura M White, Fiona J Clay, Anne-Marie Forbes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 10, 2022
IVIg-exposure and thromboembolic event risk: findings from the UK Biobank
Mahima Kapoor, Ian Hunt, Jennifer Spillane, et al.
Practical Neurology
|
September 12, 2025
Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)
Saiju Jacob, Maria Elena Farrugia, Channa Hewamadduma, et al.
Neuromuscular Disorders : NMD
|
April 16, 2024
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
Katherine C Dodd, Rohan Ahmed, Philip Ambrose, et al.
BMJ Neurology Open
|
June 3, 2021
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
Kushan Karunaratne, Dariush Ahrabian, Bernadette Monoghan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 14, 2024
Pharmacogenetic and microRNA mechanisms of beta blocker use on bone
Christine W Lary, Elizabeth J Atkinson, Jennifer Spillane, et al.
Med (New York, N.Y.)
|
February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis
Katherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Neurology
|
October 4, 2022
Neuromuscular Features in XL-MTM Carriers: A Cross-sectional Study in an Unselected Cohort
Daniëlle K Franken, Karlijn Bouman, Stacha F I Reumers, et al.
Emerging Infectious Diseases
|
November 20, 2019
Rhombencephalitis and Myeloradiculitis Caused by a European Subtype of Tick-Borne Encephalitis Virus
Lorna Neill, Anna M Checkley, Laura A Benjamin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience
Joana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Cochrane Database of Systematic Reviews
|
August 22, 2025
FcRn inhibitors for myasthenia gravis
Laura M White, Fiona J Clay, Anne-Marie Forbes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 10, 2022
IVIg-exposure and thromboembolic event risk: findings from the UK Biobank
Mahima Kapoor, Ian Hunt, Jennifer Spillane, et al.
Practical Neurology
|
September 12, 2025
Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)
Saiju Jacob, Maria Elena Farrugia, Channa Hewamadduma, et al.
Neuromuscular Disorders : NMD
|
April 16, 2024
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
Katherine C Dodd, Rohan Ahmed, Philip Ambrose, et al.
BMJ Neurology Open
|
June 3, 2021
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
Kushan Karunaratne, Dariush Ahrabian, Bernadette Monoghan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 14, 2024
Pharmacogenetic and microRNA mechanisms of beta blocker use on bone
Christine W Lary, Elizabeth J Atkinson, Jennifer Spillane, et al.
Med (New York, N.Y.)
|
February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis
Katherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Neurology
|
October 4, 2022
Neuromuscular Features in XL-MTM Carriers: A Cross-sectional Study in an Unselected Cohort
Daniëlle K Franken, Karlijn Bouman, Stacha F I Reumers, et al.
Emerging Infectious Diseases
|
November 20, 2019
Rhombencephalitis and Myeloradiculitis Caused by a European Subtype of Tick-Borne Encephalitis Virus
Lorna Neill, Anna M Checkley, Laura A Benjamin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience
Joana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Page
of 4